Page last updated: 2024-08-23

vindesine and Autoimmune Thrombocytopenia

vindesine has been researched along with Autoimmune Thrombocytopenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Fu, R; Huang, Y; Liu, W; Liu, X; Xue, F; Yang, R; Zhang, L1
Miyahara, M; Ureshino, H1
Brunot, A; Issler, M; Ojeda-Uribe, M1

Other Studies

3 other study(ies) available for vindesine and Autoimmune Thrombocytopenia

ArticleYear
[Efficacy and safety of rhTPO in the treatment of pediatric primary immune thrombocytopenia].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2015, Volume: 36, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Retrospective Studies; Thrombopoietin; Treatment Outcome; Vindesine

2015
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Adrenal Cortex Hormones; Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Prednisolone; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Remission, Spontaneous; Vincristine; Vindesine

2016
[Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].
    Revista medica de Chile, 2005, Volume: 133, Issue:11

    Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Treatment Outcome; Vindesine; von Willebrand Factor

2005